Field & Main Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $41.8K | Hold |
300
| – | – | 0.01% | 182 |
|
|
2025
Q4 | $36.8K | Hold |
300
| – | – | 0.01% | 185 |
|
|
2025
Q3 | $33.3K | Hold |
300
| – | – | 0.01% | 191 |
|
|
2025
Q2 | $33.3K | Hold |
300
| – | – | 0.01% | 182 |
|
|
2025
Q1 | $33.6K | Hold |
300
| – | – | 0.01% | 186 |
|
|
2024
Q4 | $27.7K | Hold |
300
| – | – | 0.01% | 191 |
|
|
2024
Q3 | $25.2K | Hold |
300
| – | – | 0.01% | 194 |
|
|
2024
Q2 | $20.6K | Sell |
300
-300
| -50% | -$20K | 0.01% | 201 |
|
|
2024
Q1 | $44K | Sell |
600
-200
| -25% | -$15.4K | 0.02% | 175 |
|
|
2023
Q4 | $64.8K | Hold |
800
| – | – | 0.03% | 162 |
|
|
2023
Q3 | $60K | Hold |
800
| – | – | 0.03% | 166 |
|
|
2023
Q2 | $61.6K | Hold |
800
| – | – | 0.03% | 165 |
|
|
2023
Q1 | $66.4K | Hold |
800
| – | – | 0.04% | 157 |
|
|
2022
Q4 | $68.7K | Sell |
800
-200
| -20% | -$15.8K | 0.04% | 154 |
|
|
2022
Q3 | $62K | Hold |
1,000
| – | – | 0.04% | 159 |
|
|
2022
Q2 | $62K | Hold |
1,000
| – | – | 0.04% | 165 |
|
|
2022
Q1 | $59K | Hold |
1,000
| – | – | 0.04% | 153 |
|
|
2021
Q4 | $73K | Hold |
1,000
| – | – | 0.04% | 150 |
|
|
2021
Q3 | $70K | Hold |
1,000
| – | – | 0.05% | 143 |
|
|
2021
Q2 | $69K | Hold |
1,000
| – | – | 0.04% | 145 |
|
|
2021
Q1 | $65K | Sell |
1,000
-300
| -23% | -$19.3K | 0.05% | 140 |
|
|
2020
Q4 | $76K | Sell |
1,300
-200
| -13% | -$12.1K | 0.06% | 130 |
|
|
2020
Q3 | $95K | Hold |
1,500
| – | – | 0.07% | 114 |
|
|
2020
Q2 | $115K | Buy |
+1,500
| New | +$115K | 0.1% | 108 |
|
|
2019
Q4 | $97K | Hold |
1,500
| – | – | 0.08% | 120 |
|
|
2019
Q3 | $95K | Hold |
1,500
| – | – | 0.09% | 117 |
|
|
2019
Q2 | $101K | Hold |
1,500
| – | – | 0.09% | 118 |
|
|
2019
Q1 | $98K | Buy |
+1,500
| New | +$99.7K | 0.09% | 121 |
|
|
2018
Q3 | $116K | Hold |
1,500
| – | – | 0.1% | 122 |
|
|
2018
Q2 | $117K | Sell |
1,500
-2,150
| -59% | -$152K | 0.11% | 122 |
|
|
2018
Q1 | $275K | Hold |
3,650
| – | – | 0.27% | 90 |
|
|
2017
Q4 | $261K | Buy |
+3,650
| New | +$277K | 0.25% | 96 |
|
|
2015
Q2 | $252K | Buy |
2,150
+250
| +13% | +$27.3K | 0.24% | 100 |
|
|
2015
Q1 | $186K | Buy |
1,900
+300
| +19% | +$30.5K | 0.17% | 101 |
|
|
2014
Q4 | $151K | Buy |
+1,600
| New | +$165K | 0.14% | 102 |
|
Other funds holding GILD
VCM
VPM
Field & Main Bank's GILD Position: Q1 2026 in Review
Field & Main Bank held its Gilead Sciences (GILD) position steady in Q1 2026 at 300 shares worth $41.8K. The position accounts for 0.01% of the portfolio, ranked #182.
Field & Main Bank first reported a position in GILD in Q4 2014 and has held it in 35 quarters since. The position peaked at $275K in Q1 2018. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Field & Main Bank held 300 shares of Gilead Sciences worth $41.8K as of Q1 2026.
- Field & Main Bank left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.01% of Field & Main Bank's portfolio in Q1 2026, its #182 holding.
- Field & Main Bank first reported a position in Gilead Sciences in Q4 2014 and has held it in 35 quarters since.
- Field & Main Bank's Gilead Sciences position peaked at $275K in Q1 2018.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.